Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hyperparathyroidism
Phenotype C0085681|hyperphosphataemia
Sentences 1
PubMedID- 26069822 Phosphate binders are therefore required, primarily to prevent and to treat secondary hyperparathyroidism that results from hyperphosphataemia, but also because of increasing concern that phosphate, and possibly calcium also, may have a central role in vascular calcification in patients with ckd [2].

Page: 1